In one study, none of the cases were considered DCIS tumor cell positive (defined as >5% of tumor cells being PD-L1+)27, whereas in a second study 11% of the cases were tumor cell positive (defined as >1% of tumor cells being PD-L1+)28. The gene discussed is CD274; the disease is ductal breast carcinoma in situ.